Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles Article Swipe
Biki Gupta
,
Bijay Kumar Poudel
,
Shiva Pathak
,
Jin Wook Tak
,
Hee Hyun Lee
,
Jee‐Heon Jeong
,
Han‐Gon Choi
,
Chul Soon Yong
,
Jong Oh Kim
·
YOU?
·
· 2015
· Open Access
·
· DOI: https://doi.org/10.1208/s12249-015-0384-z
YOU?
·
· 2015
· Open Access
·
· DOI: https://doi.org/10.1208/s12249-015-0384-z
Related Topics
Concepts
Solid lipid nanoparticle
Particle size
Box–Behnken design
Solubility
Chemistry
Nanoparticle
Imatinib
Aqueous solution
Plackett–Burman design
Chromatography
Lipophilicity
Drug
Nanotechnology
Materials science
Nuclear chemistry
Pharmacology
Stereochemistry
Response surface methodology
Organic chemistry
Physical chemistry
Medicine
Immunology
Myeloid leukemia
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1208/s12249-015-0384-z
- https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdf
- OA Status
- bronze
- Cited By
- 70
- References
- 41
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W1134336137
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W1134336137Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1208/s12249-015-0384-zDigital Object Identifier
- Title
-
Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid NanoparticlesWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2015Year of publication
- Publication date
-
2015-08-24Full publication date if available
- Authors
-
Biki Gupta, Bijay Kumar Poudel, Shiva Pathak, Jin Wook Tak, Hee Hyun Lee, Jee‐Heon Jeong, Han‐Gon Choi, Chul Soon Yong, Jong Oh KimList of authors in order
- Landing page
-
https://doi.org/10.1208/s12249-015-0384-zPublisher landing page
- PDF URL
-
https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdfDirect OA link when available
- Concepts
-
Solid lipid nanoparticle, Particle size, Box–Behnken design, Solubility, Chemistry, Nanoparticle, Imatinib, Aqueous solution, Plackett–Burman design, Chromatography, Lipophilicity, Drug, Nanotechnology, Materials science, Nuclear chemistry, Pharmacology, Stereochemistry, Response surface methodology, Organic chemistry, Physical chemistry, Medicine, Immunology, Myeloid leukemiaTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
70Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 8, 2024: 2, 2023: 7, 2022: 12, 2021: 9Per-year citation counts (last 5 years)
- References (count)
-
41Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W1134336137 |
|---|---|
| doi | https://doi.org/10.1208/s12249-015-0384-z |
| ids.doi | https://doi.org/10.1208/s12249-015-0384-z |
| ids.mag | 1134336137 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/26304931 |
| ids.openalex | https://openalex.org/W1134336137 |
| fwci | 3.08453967 |
| mesh[0].qualifier_ui | Q000379 |
| mesh[0].descriptor_ui | D002626 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | methods |
| mesh[0].descriptor_name | Chemistry, Pharmaceutical |
| mesh[1].qualifier_ui | Q000379 |
| mesh[1].descriptor_ui | D004339 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | methods |
| mesh[1].descriptor_name | Drug Compounding |
| mesh[2].qualifier_ui | Q000138 |
| mesh[2].descriptor_ui | D000068877 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | chemical synthesis |
| mesh[2].descriptor_name | Imatinib Mesylate |
| mesh[3].qualifier_ui | Q000493 |
| mesh[3].descriptor_ui | D000068877 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | pharmacokinetics |
| mesh[3].descriptor_name | Imatinib Mesylate |
| mesh[4].qualifier_ui | Q000138 |
| mesh[4].descriptor_ui | D008055 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | chemical synthesis |
| mesh[4].descriptor_name | Lipids |
| mesh[5].qualifier_ui | Q000493 |
| mesh[5].descriptor_ui | D008055 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | pharmacokinetics |
| mesh[5].descriptor_name | Lipids |
| mesh[6].qualifier_ui | Q000737 |
| mesh[6].descriptor_ui | D053758 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | chemistry |
| mesh[6].descriptor_name | Nanoparticles |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D053758 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Nanoparticles |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D010316 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Particle Size |
| mesh[9].qualifier_ui | Q000379 |
| mesh[9].descriptor_ui | D014961 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | methods |
| mesh[9].descriptor_name | X-Ray Diffraction |
| mesh[10].qualifier_ui | Q000379 |
| mesh[10].descriptor_ui | D002626 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | methods |
| mesh[10].descriptor_name | Chemistry, Pharmaceutical |
| mesh[11].qualifier_ui | Q000379 |
| mesh[11].descriptor_ui | D004339 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | methods |
| mesh[11].descriptor_name | Drug Compounding |
| mesh[12].qualifier_ui | Q000138 |
| mesh[12].descriptor_ui | D000068877 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | chemical synthesis |
| mesh[12].descriptor_name | Imatinib Mesylate |
| mesh[13].qualifier_ui | Q000493 |
| mesh[13].descriptor_ui | D000068877 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | pharmacokinetics |
| mesh[13].descriptor_name | Imatinib Mesylate |
| mesh[14].qualifier_ui | Q000138 |
| mesh[14].descriptor_ui | D008055 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | chemical synthesis |
| mesh[14].descriptor_name | Lipids |
| mesh[15].qualifier_ui | Q000493 |
| mesh[15].descriptor_ui | D008055 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | pharmacokinetics |
| mesh[15].descriptor_name | Lipids |
| mesh[16].qualifier_ui | Q000737 |
| mesh[16].descriptor_ui | D053758 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | chemistry |
| mesh[16].descriptor_name | Nanoparticles |
| mesh[17].qualifier_ui | Q000378 |
| mesh[17].descriptor_ui | D053758 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | metabolism |
| mesh[17].descriptor_name | Nanoparticles |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D010316 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Particle Size |
| mesh[19].qualifier_ui | Q000379 |
| mesh[19].descriptor_ui | D014961 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | methods |
| mesh[19].descriptor_name | X-Ray Diffraction |
| type | article |
| title | Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles |
| biblio.issue | 3 |
| biblio.volume | 17 |
| biblio.last_page | 662 |
| biblio.first_page | 652 |
| topics[0].id | https://openalex.org/T12477 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9717000126838684 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Toxin Mechanisms and Immunotoxins |
| topics[1].id | https://openalex.org/T10704 |
| topics[1].field.id | https://openalex.org/fields/30 |
| topics[1].field.display_name | Pharmacology, Toxicology and Pharmaceutics |
| topics[1].score | 0.9643999934196472 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/3003 |
| topics[1].subfield.display_name | Pharmaceutical Science |
| topics[1].display_name | Advancements in Transdermal Drug Delivery |
| topics[2].id | https://openalex.org/T11020 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9478999972343445 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | Immune Cell Function and Interaction |
| is_xpac | False |
| apc_list.value | 2890 |
| apc_list.currency | EUR |
| apc_list.value_usd | 3690 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C199529486 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8267227411270142 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q7557912 |
| concepts[0].display_name | Solid lipid nanoparticle |
| concepts[1].id | https://openalex.org/C187530423 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7993475198745728 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q7140503 |
| concepts[1].display_name | Particle size |
| concepts[2].id | https://openalex.org/C170295934 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7584010362625122 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q4952019 |
| concepts[2].display_name | Box–Behnken design |
| concepts[3].id | https://openalex.org/C155574463 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6122272610664368 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q170731 |
| concepts[3].display_name | Solubility |
| concepts[4].id | https://openalex.org/C185592680 |
| concepts[4].level | 0 |
| concepts[4].score | 0.5706411600112915 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[4].display_name | Chemistry |
| concepts[5].id | https://openalex.org/C155672457 |
| concepts[5].level | 2 |
| concepts[5].score | 0.5508371591567993 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q61231 |
| concepts[5].display_name | Nanoparticle |
| concepts[6].id | https://openalex.org/C2777583451 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4784400761127472 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q177094 |
| concepts[6].display_name | Imatinib |
| concepts[7].id | https://openalex.org/C184651966 |
| concepts[7].level | 2 |
| concepts[7].score | 0.47615668177604675 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q906356 |
| concepts[7].display_name | Aqueous solution |
| concepts[8].id | https://openalex.org/C111374699 |
| concepts[8].level | 3 |
| concepts[8].score | 0.46230047941207886 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7200396 |
| concepts[8].display_name | Plackett–Burman design |
| concepts[9].id | https://openalex.org/C43617362 |
| concepts[9].level | 1 |
| concepts[9].score | 0.4503938555717468 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q170050 |
| concepts[9].display_name | Chromatography |
| concepts[10].id | https://openalex.org/C201399114 |
| concepts[10].level | 2 |
| concepts[10].score | 0.4357397258281708 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q898401 |
| concepts[10].display_name | Lipophilicity |
| concepts[11].id | https://openalex.org/C2780035454 |
| concepts[11].level | 2 |
| concepts[11].score | 0.43217992782592773 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q8386 |
| concepts[11].display_name | Drug |
| concepts[12].id | https://openalex.org/C171250308 |
| concepts[12].level | 1 |
| concepts[12].score | 0.3645084500312805 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[12].display_name | Nanotechnology |
| concepts[13].id | https://openalex.org/C192562407 |
| concepts[13].level | 0 |
| concepts[13].score | 0.3624970018863678 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[13].display_name | Materials science |
| concepts[14].id | https://openalex.org/C13965031 |
| concepts[14].level | 1 |
| concepts[14].score | 0.3426505923271179 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q243545 |
| concepts[14].display_name | Nuclear chemistry |
| concepts[15].id | https://openalex.org/C98274493 |
| concepts[15].level | 1 |
| concepts[15].score | 0.32465219497680664 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[15].display_name | Pharmacology |
| concepts[16].id | https://openalex.org/C71240020 |
| concepts[16].level | 1 |
| concepts[16].score | 0.22139376401901245 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q186011 |
| concepts[16].display_name | Stereochemistry |
| concepts[17].id | https://openalex.org/C150077022 |
| concepts[17].level | 2 |
| concepts[17].score | 0.1898086667060852 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q3136137 |
| concepts[17].display_name | Response surface methodology |
| concepts[18].id | https://openalex.org/C178790620 |
| concepts[18].level | 1 |
| concepts[18].score | 0.1404750645160675 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[18].display_name | Organic chemistry |
| concepts[19].id | https://openalex.org/C147789679 |
| concepts[19].level | 1 |
| concepts[19].score | 0.07464456558227539 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q11372 |
| concepts[19].display_name | Physical chemistry |
| concepts[20].id | https://openalex.org/C71924100 |
| concepts[20].level | 0 |
| concepts[20].score | 0.0643109679222107 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[20].display_name | Medicine |
| concepts[21].id | https://openalex.org/C203014093 |
| concepts[21].level | 1 |
| concepts[21].score | 0.0 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[21].display_name | Immunology |
| concepts[22].id | https://openalex.org/C2778729363 |
| concepts[22].level | 2 |
| concepts[22].score | 0.0 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q11688946 |
| concepts[22].display_name | Myeloid leukemia |
| keywords[0].id | https://openalex.org/keywords/solid-lipid-nanoparticle |
| keywords[0].score | 0.8267227411270142 |
| keywords[0].display_name | Solid lipid nanoparticle |
| keywords[1].id | https://openalex.org/keywords/particle-size |
| keywords[1].score | 0.7993475198745728 |
| keywords[1].display_name | Particle size |
| keywords[2].id | https://openalex.org/keywords/box–behnken-design |
| keywords[2].score | 0.7584010362625122 |
| keywords[2].display_name | Box–Behnken design |
| keywords[3].id | https://openalex.org/keywords/solubility |
| keywords[3].score | 0.6122272610664368 |
| keywords[3].display_name | Solubility |
| keywords[4].id | https://openalex.org/keywords/chemistry |
| keywords[4].score | 0.5706411600112915 |
| keywords[4].display_name | Chemistry |
| keywords[5].id | https://openalex.org/keywords/nanoparticle |
| keywords[5].score | 0.5508371591567993 |
| keywords[5].display_name | Nanoparticle |
| keywords[6].id | https://openalex.org/keywords/imatinib |
| keywords[6].score | 0.4784400761127472 |
| keywords[6].display_name | Imatinib |
| keywords[7].id | https://openalex.org/keywords/aqueous-solution |
| keywords[7].score | 0.47615668177604675 |
| keywords[7].display_name | Aqueous solution |
| keywords[8].id | https://openalex.org/keywords/plackett–burman-design |
| keywords[8].score | 0.46230047941207886 |
| keywords[8].display_name | Plackett–Burman design |
| keywords[9].id | https://openalex.org/keywords/chromatography |
| keywords[9].score | 0.4503938555717468 |
| keywords[9].display_name | Chromatography |
| keywords[10].id | https://openalex.org/keywords/lipophilicity |
| keywords[10].score | 0.4357397258281708 |
| keywords[10].display_name | Lipophilicity |
| keywords[11].id | https://openalex.org/keywords/drug |
| keywords[11].score | 0.43217992782592773 |
| keywords[11].display_name | Drug |
| keywords[12].id | https://openalex.org/keywords/nanotechnology |
| keywords[12].score | 0.3645084500312805 |
| keywords[12].display_name | Nanotechnology |
| keywords[13].id | https://openalex.org/keywords/materials-science |
| keywords[13].score | 0.3624970018863678 |
| keywords[13].display_name | Materials science |
| keywords[14].id | https://openalex.org/keywords/nuclear-chemistry |
| keywords[14].score | 0.3426505923271179 |
| keywords[14].display_name | Nuclear chemistry |
| keywords[15].id | https://openalex.org/keywords/pharmacology |
| keywords[15].score | 0.32465219497680664 |
| keywords[15].display_name | Pharmacology |
| keywords[16].id | https://openalex.org/keywords/stereochemistry |
| keywords[16].score | 0.22139376401901245 |
| keywords[16].display_name | Stereochemistry |
| keywords[17].id | https://openalex.org/keywords/response-surface-methodology |
| keywords[17].score | 0.1898086667060852 |
| keywords[17].display_name | Response surface methodology |
| keywords[18].id | https://openalex.org/keywords/organic-chemistry |
| keywords[18].score | 0.1404750645160675 |
| keywords[18].display_name | Organic chemistry |
| keywords[19].id | https://openalex.org/keywords/physical-chemistry |
| keywords[19].score | 0.07464456558227539 |
| keywords[19].display_name | Physical chemistry |
| keywords[20].id | https://openalex.org/keywords/medicine |
| keywords[20].score | 0.0643109679222107 |
| keywords[20].display_name | Medicine |
| language | en |
| locations[0].id | doi:10.1208/s12249-015-0384-z |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S1234972 |
| locations[0].source.issn | 1530-9932 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1530-9932 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | AAPS PharmSciTech |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| locations[0].source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| locations[0].license | |
| locations[0].pdf_url | https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | AAPS PharmSciTech |
| locations[0].landing_page_url | https://doi.org/10.1208/s12249-015-0384-z |
| locations[1].id | pmid:26304931 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | AAPS PharmSciTech |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/26304931 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5037464191 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-2315-1026 |
| authorships[0].author.display_name | Biki Gupta |
| authorships[0].countries | KR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[0].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[0].institutions[0].id | https://openalex.org/I55240360 |
| authorships[0].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[0].institutions[0].country_code | KR |
| authorships[0].institutions[0].display_name | Yeungnam University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Biki Gupta |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[1].author.id | https://openalex.org/A5101555151 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4128-8261 |
| authorships[1].author.display_name | Bijay Kumar Poudel |
| authorships[1].countries | KR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[1].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[1].institutions[0].id | https://openalex.org/I55240360 |
| authorships[1].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[1].institutions[0].country_code | KR |
| authorships[1].institutions[0].display_name | Yeungnam University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Bijay Kumar Poudel |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[2].author.id | https://openalex.org/A5043260085 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Shiva Pathak |
| authorships[2].countries | KR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[2].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[2].institutions[0].id | https://openalex.org/I55240360 |
| authorships[2].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[2].institutions[0].country_code | KR |
| authorships[2].institutions[0].display_name | Yeungnam University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Shiva Pathak |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[3].author.id | https://openalex.org/A5074108128 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Jin Wook Tak |
| authorships[3].countries | KR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[3].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[3].institutions[0].id | https://openalex.org/I55240360 |
| authorships[3].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[3].institutions[0].country_code | KR |
| authorships[3].institutions[0].display_name | Yeungnam University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Jin Wook Tak |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[4].author.id | https://openalex.org/A5070148273 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Hee Hyun Lee |
| authorships[4].countries | KR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[4].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[4].institutions[0].id | https://openalex.org/I55240360 |
| authorships[4].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[4].institutions[0].country_code | KR |
| authorships[4].institutions[0].display_name | Yeungnam University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Hee Hyun Lee |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[5].author.id | https://openalex.org/A5008035486 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7120-169X |
| authorships[5].author.display_name | Jee‐Heon Jeong |
| authorships[5].countries | KR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[5].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[5].institutions[0].id | https://openalex.org/I55240360 |
| authorships[5].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[5].institutions[0].country_code | KR |
| authorships[5].institutions[0].display_name | Yeungnam University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Jee-Heon Jeong |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[6].author.id | https://openalex.org/A5034418015 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Han‐Gon Choi |
| authorships[6].countries | KR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4575257 |
| authorships[6].affiliations[0].raw_affiliation_string | College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University,, Ansan, South Korea |
| authorships[6].institutions[0].id | https://openalex.org/I4575257 |
| authorships[6].institutions[0].ror | https://ror.org/046865y68 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I4575257 |
| authorships[6].institutions[0].country_code | KR |
| authorships[6].institutions[0].display_name | Hanyang University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Han-Gon Choi |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University,, Ansan, South Korea |
| authorships[7].author.id | https://openalex.org/A5086090575 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-9242-2117 |
| authorships[7].author.display_name | Chul Soon Yong |
| authorships[7].countries | KR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[7].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[7].institutions[0].id | https://openalex.org/I55240360 |
| authorships[7].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[7].institutions[0].country_code | KR |
| authorships[7].institutions[0].display_name | Yeungnam University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Chul Soon Yong |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[8].author.id | https://openalex.org/A5083751923 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-4929-851X |
| authorships[8].author.display_name | Jong Oh Kim |
| authorships[8].countries | KR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I55240360 |
| authorships[8].affiliations[0].raw_affiliation_string | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| authorships[8].institutions[0].id | https://openalex.org/I55240360 |
| authorships[8].institutions[0].ror | https://ror.org/05yc6p159 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I55240360 |
| authorships[8].institutions[0].country_code | KR |
| authorships[8].institutions[0].display_name | Yeungnam University |
| authorships[8].author_position | last |
| authorships[8].raw_author_name | Jong Oh Kim |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | College of Pharmacy, Yeungnam University, Gyeongsan, South Korea |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdf |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12477 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9717000126838684 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Toxin Mechanisms and Immunotoxins |
| related_works | https://openalex.org/W4285549210, https://openalex.org/W2199475220, https://openalex.org/W4205423654, https://openalex.org/W2808946280, https://openalex.org/W1989997424, https://openalex.org/W2783235116, https://openalex.org/W2395228194, https://openalex.org/W2353231556, https://openalex.org/W2594928232, https://openalex.org/W3037355166 |
| cited_by_count | 70 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 8 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2023 |
| counts_by_year[2].cited_by_count | 7 |
| counts_by_year[3].year | 2022 |
| counts_by_year[3].cited_by_count | 12 |
| counts_by_year[4].year | 2021 |
| counts_by_year[4].cited_by_count | 9 |
| counts_by_year[5].year | 2020 |
| counts_by_year[5].cited_by_count | 7 |
| counts_by_year[6].year | 2019 |
| counts_by_year[6].cited_by_count | 4 |
| counts_by_year[7].year | 2018 |
| counts_by_year[7].cited_by_count | 9 |
| counts_by_year[8].year | 2017 |
| counts_by_year[8].cited_by_count | 7 |
| counts_by_year[9].year | 2016 |
| counts_by_year[9].cited_by_count | 4 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1208/s12249-015-0384-z |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S1234972 |
| best_oa_location.source.issn | 1530-9932 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 1530-9932 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | AAPS PharmSciTech |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| best_oa_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | AAPS PharmSciTech |
| best_oa_location.landing_page_url | https://doi.org/10.1208/s12249-015-0384-z |
| primary_location.id | doi:10.1208/s12249-015-0384-z |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S1234972 |
| primary_location.source.issn | 1530-9932 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1530-9932 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | AAPS PharmSciTech |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900, https://openalex.org/P4310319965 |
| primary_location.source.host_organization_lineage_names | Springer Science+Business Media, Springer Nature |
| primary_location.license | |
| primary_location.pdf_url | https://link.springer.com/content/pdf/10.1208/s12249-015-0384-z.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | AAPS PharmSciTech |
| primary_location.landing_page_url | https://doi.org/10.1208/s12249-015-0384-z |
| publication_date | 2015-08-24 |
| publication_year | 2015 |
| referenced_works | https://openalex.org/W2090004346, https://openalex.org/W6743250370, https://openalex.org/W2002738924, https://openalex.org/W1579046626, https://openalex.org/W2054189154, https://openalex.org/W2055449190, https://openalex.org/W1971120211, https://openalex.org/W2049975169, https://openalex.org/W2026674730, https://openalex.org/W2022154646, https://openalex.org/W2007329636, https://openalex.org/W1990876023, https://openalex.org/W1998154903, https://openalex.org/W2059248480, https://openalex.org/W1969937794, https://openalex.org/W237401350, https://openalex.org/W2032962341, https://openalex.org/W1976359124, https://openalex.org/W1964392067, https://openalex.org/W7073534298, https://openalex.org/W2013630484, https://openalex.org/W1968098666, https://openalex.org/W2163241139, https://openalex.org/W2082418952, https://openalex.org/W2100225360, https://openalex.org/W2146655098, https://openalex.org/W7074194765, https://openalex.org/W2064597901, https://openalex.org/W1976903802, https://openalex.org/W2026205914, https://openalex.org/W2160021888, https://openalex.org/W2035381945, https://openalex.org/W195173163, https://openalex.org/W1997787046, https://openalex.org/W2008444239, https://openalex.org/W2018057636, https://openalex.org/W3201243225, https://openalex.org/W1997762982, https://openalex.org/W1528531447, https://openalex.org/W2094970696, https://openalex.org/W1236654308 |
| referenced_works_count | 41 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 9 |
| citation_normalized_percentile.value | 0.90476666 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |